Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group. 1995

I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
St. Michael's Hospital, University of Toronto, Ontario.

A randomized study was done to compare the efficacy of clarithromycin 250 mg or 500 mg b.i.d., vs. cefaclor 250 mg or 500 mg t.i.d. for 7-14 d in 197 evaluable patients with lower respiratory tract infection. Ninety-five patients received clarithromycin, 88 with acute bronchitis or exacerbation of chronic bronchitis, and 7 with pneumonia. One hundred and two patients received cefaclor, 86 with bronchitis and 16 with pneumonia. Ten patients (10.5%) in the clarithromycin group did not complete the trial, 5 (5.3%) because of adverse event, and 3 (3.2%) because of clinical failure. Similarly, 11 patients (10.8%) did not complete cefaclor, 2 (2%) because of adverse event, and 7 (6.9%) because of clinical failure. Clinical cure or improvement was observed in 90 (94.7%) of patients on clarithromycin vs. 92 (90.2%) on cefaclor, p = 0.66. Bacteriologic cure was seen in 26/36 patients (72.2%) on clarithromycin vs. 28/40 patients (70%) on cefaclor, p = 0.28. Clarithromycin is just as effective as cefaclor for lower respiratory tract infections and is well tolerated.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002433 Cefaclor Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))-,Ceclor,Cefaclor Anhydrous,Cefaclor Monohydrate,Keclor,Lilly 99638,S-6472,S 6472,S6472
D005260 Female Females
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus

Related Publications

I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
January 1991, Diagnostic microbiology and infectious disease,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
January 1988, Clinical therapeutics,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
August 1993, PharmacoEconomics,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
March 1998, The Journal of antimicrobial chemotherapy,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
September 1991, The Journal of hospital infection,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
August 1989, Journal of chemotherapy (Florence, Italy),
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
February 1988, Archives of internal medicine,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
September 1991, The American journal of medicine,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
August 1988, La Clinica terapeutica,
I W Fong, and J Laforge, and J Dubois, and D Small, and R Grossman, and R Zakhari
June 1993, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!